![]() |
市場調查報告書
商品編碼
1843282
皮膚移植的全球市場:移植片類型·產品類型·用途·終端用戶·各地區 (~2034年)Global Skin Graft Market Research Report Information by Graft Type, by Product Type, by Application, by End User, and by Region Forecast till 2034 |
||||||
預計到 2034 年,全球植皮市場規模將達到 26.1958 億美元,預測期內複合年增長率為 6.59%。植皮是一種醫療程序,從捐贈者部位獲取健康皮膚,並將其移植到受傷或缺失的部位。該程序旨在促進燒傷、創傷和手術後的皮膚修復和再生。
全球植皮市場的發展受到糖尿病足潰瘍和壓瘡等慢性傷口數量增加的驅動。糖尿病、肥胖症和血管疾病的增多推動了對先進治療方法的需求。植皮在組織修復和感染控制方面非常有效。生物工程植皮和幹細胞植皮等外科技術的進步已證明能夠有效促進癒合,從而推動市場需求的長期成長和技術進步。
報告屬性詳細內容
美國仍然是領先的地區,得益於其強大的先進醫療設施、深厚的患者知識和數據,以及大量患有慢性傷口疾病的人群。同時,由於政府的優惠政策支援和傷口管理技術的進步,加拿大也正成為一個備受關注的潛力市場。
德國、英國和法國日益重視生物工程皮膚和移植材料,並確立了其在歐洲的領先地位。優惠的醫療政策和廣泛的患者資訊為歐洲市場的長期可持續成長奠定了基礎。
預計2024年,亞太市場規模將達到2.736億美元,年複合成長率高達7.55%。政府對醫療產業的支持性政策和再生醫學的進步正在進一步推動該地區的成長。
預計2024年,拉丁美洲市場規模將達到8,650萬美元,年複合成長率為5.41%。巴西和墨西哥等國家正日益重視現代傷口照護方法,推動市場成長。該地區正在逐步採用先進的手術技術和生物工程皮膚移植材料。
預計2024年,中東和非洲市場規模將達到6,673萬美元,複合年增長率為4.99%。市場擴張的動力來自整形外科手術的增加、醫療保健標準的提高以及醫院基礎設施投資的增加。海灣合作委員會國家,尤其是阿聯酋和沙烏地阿拉伯,是主要貢獻者,南非也正在成為一個值得關注的新興市場。
本報告研究了全球皮膚移植市場,並提供了市場定義和概述、影響市場成長的各種因素分析、市場規模趨勢和預測、各細分市場、地區和主要國家的細分情況、競爭格局以及主要公司的概況。
Global Skin Graft Market Research Report Information by Graft Type (Autograft, Allograft, Xenograft), by Product Type (Dermatome, Wound Debridement Device, Others), by Application (Pressure & Venous Ulcers, Diabetic Foot Ulcers, Burns, Surgical Wounds, Others), by End User (Hospitals, Ambulatory Surgery Centers, Specialty Centers), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Forecast till 2034
Industry Overview
By 2034, the Global Skin Graft Market is expected to attain a valuation of USD 2,619.58 million, expanding at a steady CAGR of 6.59% during the forecast period. Skin grafting involves taking healthy skin from a donor site and transplanting it to an injured or defective area of the body. This medical procedure helps repair and regenerate skin after burns, trauma, or surgeries.
The global skin graft market is driven by the rising number of chronic wounds like diabetic foot ulcer and pressure ulcer diseases. The rise in diabetes, obesity, and vascular diseases have led to a considerable demand for advanced healing modalities. The skin grafts are quite effective in repairing tissue and combating infections. Advances in surgical technologies like bioengineering skin grafts and stem cell skin grafts have shown to be efficient in recovery and have led to an increase in longitudinal demand and technological advancement in the market.
Major Company Development
The major company development in Surtex Instruments is a global expansion of market presence through cooperation and tradeshows, the launch of the Infinex microsurgery series, and compliance with ISO 13485 Quality Management Standard. Surtex's continuous investment in the development of innovative products, sustainable practices, and innovation driven by customer needs has fortified the company's intent to provide reliable and cost-effective surgical solutions across diverse specialities around the world.
Major players in the global skin graft market are De Soutter Medical, B. Braun SE, Zimmer Biomet Holdings, Inc., Shaanxi Xingmao Industry Co., Ltd, Integra LifeSciences, AYGUN, Paramount Surgimed Ltd., Ribbel International Limited, Novo Surgical, Inc., and Surtex Instruments.
Report Attribute Details
Industry Segmentations
The United States remains a dominant region with a good base of advanced healthcare facilities, a thorough knowledge of the patients, and a large population group afflicted with chronic wound diseases. Canada is also showing good promise due to the friendly policies of the government ahead and advancements in techniques for wound management.
Germany, the UK, and France are becoming leaders in the presence of bioengineered skin and graft materials. The favourable health policy, coupled with increasing patient information, leads to a sound base for good longevity in growth in Europe.
Asia Pacific market value is expected to be USD 273.60 million in 2024 in the region and is likely to become the fastest growing section of the table at a healthy 7.55 percent CAGR. Government supported the health initiatives and advances in regenerative medicine also remains a growth area in the region.
The Latin America Skin Graft Market recorded a valuation of USD 86.50 million in 2024 and is projected to expand at a CAGR of 5.41%. Countries such as Brazil and Mexico are driving growth with an increasing focus on modern wound care practices. The region is gradually integrating advanced surgical techniques and bioengineered graft materials.
In 2024, the Middle East & Africa Skin Graft Market reached USD 66.73 million and is projected to grow at a CAGR of 4.99%. Market expansion is supported by the rise in reconstructive surgeries, improving healthcare standards, and growing investments in hospital infrastructure. GCC countries, particularly the UAE and Saudi Arabia, are key contributors, while South Africa is emerging as a notable market.